Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00828555 |
Recruitment Status
:
Completed
First Posted
: January 26, 2009
Last Update Posted
: October 16, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
PURPOSE To develop, implement, and evaluate the effectiveness of a program designed to assist community Ob/Gyns in vaccinating adolescent and adult women against vaccine-preventable diseases.
SPECIFIC AIMS
-
Determine the feasibility of implementing a successful vaccination program for adolescent and adult women in Ob/Gyn offices by direct assessment of medical personnel & office staff on their:
- Attitudes towards vaccination of women against preventable diseases
- Perceived barriers to implementing a program to vaccinate women in their offices
- Ideas on how to overcome barriers to successful program implementation
- Current vaccination practices and office-specific administrative processes
- Design & implement a program for Ob/Gyns to vaccinate women against human papillomavirus, influenza, & pertussis
-
Determine the effectiveness of the vaccination program based on
- Pre- and post-program vaccination rates
- Program satisfaction amongst Ob/Gyn providers and office staff
- Willingness to continue and possibly extend the program to additional vaccines
- Quantify the level of support and resources needed to develop and implement the vaccination program
Condition or disease | Intervention/treatment |
---|---|
Influenza Vaccine Papillomavirus Infection Pertussis | Other: Vaccination Program |
Study Type : | Observational |
Actual Enrollment : | 3988 participants |
Official Title: | Effectiveness of a Vaccination Program in the Community Ob/Gyn Setting |
Study Start Date : | November 2008 |
Actual Primary Completion Date : | April 2009 |
Actual Study Completion Date : | February 2012 |

-
Other: Vaccination Program
- Implementation and measurement of a health services intervention in community or private Ob/Gyn practices to improve the delivery of standard clinical care to vaccinate women against human papillomavirus, influenza, & pertussis. [ Time Frame: Full-scale program implementation will cover a 12 month period, tentatively planned to begin in April 2009. ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 12 Years to 26 Years (Child, Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Population Groups:
Adults
Minors
Patients
Pregnant Women
Fetuses
Inclusion Criteria:
- 4-5 community Ob/Gyn practices

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00828555
United States, North Carolina | |
Westside OBGYN | |
Burlington, North Carolina, United States | |
DWHA | |
Durham, North Carolina, United States, 27707 | |
Atrium OBGYN | |
Raleigh, North Carolina, United States | |
Blue Ridge OBGYN | |
Raleigh, North Carolina, United States |
Principal Investigator: | Geeta Swamy, MD | Duke University |
Responsible Party: | Duke University |
ClinicalTrials.gov Identifier: | NCT00828555 History of Changes |
Other Study ID Numbers: |
Pro00011038 |
First Posted: | January 26, 2009 Key Record Dates |
Last Update Posted: | October 16, 2012 |
Last Verified: | September 2012 |
Keywords provided by Duke University:
HPV vaccine Tdap vaccine |
Additional relevant MeSH terms:
Papillomavirus Infections DNA Virus Infections Virus Diseases Tumor Virus Infections |
Vaccines Immunologic Factors Physiological Effects of Drugs |